These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark. Kofoed K, Petersen E. J Travel Med; 2003 Oct 17; 10(3):150-4. PubMed ID: 12757688 [Abstract] [Full Text] [Related]
4. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers. Toovey S, Nieforth K, Smith P, Schlagenhauf P, Adamcova M, Tatt I, Tomianovic D, Schnetzler G. Travel Med Infect Dis; 2014 Jun 17; 12(6 Pt B):726-32. PubMed ID: 25443997 [Abstract] [Full Text] [Related]
7. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team. Høgh B, Clarke PD, Camus D, Nothdurft HD, Overbosch D, Günther M, Joubert I, Kain KC, Shaw D, Roskell NS, Chulay JD, Malarone International Study Team. Lancet; 2000 Dec 02; 356(9245):1888-94. PubMed ID: 11130385 [Abstract] [Full Text] [Related]
11. Current status and replies to frequently posed questions on atovaquone plus proguanil (Malarone) for the prevention of malaria. Kain KC. BioDrugs; 2003 Dec 02; 17 Suppl 1():23-8. PubMed ID: 12785875 [Abstract] [Full Text] [Related]
12. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS, Chulay JD, Malarone International Study Team. Clin Infect Dis; 2001 Oct 01; 33(7):1015-21. PubMed ID: 11528574 [Abstract] [Full Text] [Related]
13. Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: retrospective observational data. Zuckerman JN, Batty AJ, Jones ME. Travel Med Infect Dis; 2009 Nov 01; 7(6):329-36. PubMed ID: 19945009 [Abstract] [Full Text] [Related]
15. Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa. Lachish T, Bar-Meir M, Eisenberg N, Schwartz E. J Travel Med; 2016 Jun 01; 23(6):. PubMed ID: 27625401 [Abstract] [Full Text] [Related]
16. [What is the value of the combination atovaquone-proguanil for the clinician?]. Delmont J. Med Trop (Mars); 2002 Jun 01; 62(3):232-6. PubMed ID: 12244917 [Abstract] [Full Text] [Related]
18. Malaria prevention recommendations for risk groups visiting sub-Saharan Africa: A survey of European expert opinion and international recommendations. Shellvarajah M, Hatz C, Schlagenhauf P. Travel Med Infect Dis; 2017 Sep 01; 19():49-55. PubMed ID: 28939502 [Abstract] [Full Text] [Related]
19. [The proper use of antimalarial drugs currently available]. Bourgeade A, Delmont J. Bull Soc Pathol Exot; 1998 Sep 01; 91(5 Pt 1-2):493-6. PubMed ID: 10078393 [Abstract] [Full Text] [Related]
20. Utilisation of malaria prophylaxis: the effect of changes in guidelines in The Netherlands, 1993-1998. van Riemsdijk MM, Sturkenboom MC, Schilthuis HJ, Stricker BH. Pharm World Sci; 2003 Feb 01; 25(1):21-4. PubMed ID: 12661472 [Abstract] [Full Text] [Related] Page: [Next] [New Search]